ICD-10-CM Billable Code

C82.00

Follicular lymphoma grade I, unspecified site

Clinical Classification Guidelines

Medical Intelligence & Overview

Follicular lymphoma is a type of non-Hodgkin lymphoma, which originates in the lymphatic system. Specifically, grade I follicular lymphoma is considered a low-grade or slow-growing form of this cancer. It involves the abnormal growth of lymphocytes, a type of white blood cell that plays a crucial role in the immune system. Although it can appear in various parts of the body, in this context, the disease has been identified at an unspecified site, meaning its exact location is not determined. Understanding the characteristics of follicular lymphoma grade I helps patients grasp its nature, potential implications, and general approaches to management.

Causes & Symptoms

Clinical Causes: Genetic mutations within lymphocytes that cause abnormal growth Age-related changes, as the risk increases with advancing age Possible environmental exposures, such as certain chemicals or radiation A family history of lymphomas or other lymphocyte-related malignancies Immune system dysregulation or autoimmune conditions

Key Symptoms: Painless swelling in lymph nodes, often in the neck, armpits, or groin Fatigue or feeling unusually tired Unexplained weight loss Persistent fever without infection Night sweats Itching or skin changes in some cases

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a combination of medical evaluation and tests. Initial assessment includes physical examination of lymph nodes and review of symptoms. Confirmatory diagnosis is usually obtained through biopsy of affected lymph tissue, where microscopic examination reveals characteristic features of follicular lymphoma. Additional tests that may assist in diagnosis and staging include:

Treatment Protocols: Treatment strategies depend on various factors, including disease stage, patient health, and preferences. Common approaches include: - **Watchful waiting**: In cases where the disease is slow-growing and asymptomatic, careful monitoring may be recommended before initiating treatment. - **Chemotherapy**: Use of drugs to destroy cancer cells. - **Immunotherapy**: Targeted therapies that help the immune system recognize and fight lymphoma cells. - **Radiation therapy**: Localized treatment for specific affected areas. - **Targeted therapy**: Medications directed at specific molecules involved in lymphoma progression. - **Stem cell transplant**: In some cases, high-dose chemotherapy followed by stem cell support may be considered. Since follicular lymphoma grade I is generally slow-growing, management often involves a tailored approach, balancing treatment risks and benefits while closely monitoring disease progression.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C82.00 a billable ICD-10 code?
Yes, C82.00 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C82.00?
Clinical documentation must specify the nature of Follicular lymphoma grade I, unspecified site and any associated comorbidities for accurate reporting.

Cite this Clinical Reference